The Efficacy of Photobiomodulation Therapy in Improving Cognitive Function and Reducing Depression and Anxiety in Patients with Mild-to-Moderate Dementia: A Double-Blinded Randomized Clinical Trial

<b><i>Background:</i></b> There is strong evidence supporting the effectiveness of photobiomodulation therapy (PBMT) in improving neuronal damage and enhancing neuropsychological activities. However, there is limited research on the effects of this method on cognitive function and mood disorders. This project aimed to evaluate the potential benefits of PBMT in improving cognitive status and mood disorders in patients with dementia. <b><i>Methods:</i></b> In this randomized, double-blinded, controlled trial, 30 patients with mild-to-moderate dementia participated. The patients were divided into two groups: the first group (<i>n</i> = 15) received standard treatment along with PBMT, whereas the second group (<i>n</i> = 15) received standard treatment along with the use of an off-device on the head. Cognitive function, anxiety, and depression levels were assessed before, immediately after treatment, and 1 month later. <b><i>Results:</i></b> The comparison of cognitive functional score at baseline, after completing the therapeutic regimen, as well as one later showed no difference between the two groups (Table 1). Similarly, the two groups had similar mean scores for depression and anxiety at baseline and after treatment interventions. [Table: see text] <b><i>Conclusion:</i></b> The treatment likely has no significant impact on improving cognitive status or mood disorders in patients with mild-to-moderate dementia.